Clinical Trial Update: Treatment Options in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer Patients

View source ↗

Summary

A completed clinical trial sponsored by GlaxoSmithKline evaluating treatment options for HER2-positive metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Status: COMPLETED